ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 84512 | ISO 10993-1:2025 | Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process | Standarts spēkā |
| 64580 | ISO 10993-9:2019 | Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products | Standarts spēkā |
| 65918 | ISO/TR 10993-22:2017 | Biological evaluation of medical devices — Part 22: Guidance on nanomaterials | Standarts spēkā |
| 73582 | ISO/TS 37137-1:2021 | Biological evaluation of absorbable medical devices — Part 1: General requirements | Standarts spēkā |
| 55064 | ISO 10993-7:2008/Cor 1:2009 | Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals — Technical Corrigendum 1 | Standarts spēkā |
| 36406 | ISO 10993-5:2009 | Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 65052 | ISO/TR 10993-33:2015 | Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3 | Standarts spēkā |
| 83916 | ISO/TS 11796:2023 | Biological evaluation of medical devices — Requirements for interlaboratory studies to demonstrate the applicability of validated in vitro methods to assess the skin sensitization of medical devices | Standarts spēkā |
| 88205 | ISO 10993-12:2021/Amd 1:2025 | Biological evaluation of medical devices — Part 12: Sample preparation and reference materials — Amendment 1 | Standarts spēkā |
| 64887 | ISO/TR 37137:2014 | Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants | Standarts spēkā |
Displaying 131-140 of 155 results.
